Pharmacogenetics of ustekinumab in patients with moderate-to-severe plaque psoriasis.

MLA

Prieto-Pérez, Rocío, et al. “Pharmacogenetics of Ustekinumab in Patients with Moderate-to-Severe Plaque Psoriasis.” Pharmacogenomics, vol. 18, no. 2, Jan. 2017, pp. 157–64. EBSCOhost, https://doi.org/10.2217/pgs-2016-0122.

APA

Prieto-Pérez, R., Llamas-Velasco, M., Cabaleiro, T., Solano-López, G., Márquez, B., Román, M., Ochoa, D., Talegón, M., Daudén, E., & Abad-Santos, F. (2017). Pharmacogenetics of ustekinumab in patients with moderate-to-severe plaque psoriasis. Pharmacogenomics, 18(2), 157–164. https://doi.org/10.2217/pgs-2016-0122

Chicago

Prieto-Pérez, Rocío, Mar Llamas-Velasco, Teresa Cabaleiro, Guillermo Solano-López, Beatriz Márquez, Manuel Román, Dolores Ochoa, María Talegón, Esteban Daudén, and Francisco Abad-Santos. 2017. “Pharmacogenetics of Ustekinumab in Patients with Moderate-to-Severe Plaque Psoriasis.” Pharmacogenomics 18 (2): 157–64. doi:10.2217/pgs-2016-0122.